Daly's Insider Trades & SAST Disclosures
Daly's most recent trade in SkyWater Technology Inc was a trade of 11,428 Common Stock done at an average price of $8.8 . Disclosure was reported to the exchange on May 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Daly.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SkyWater Technology Inc | Edward M. Daly | Director | Grant, award, or other acquisition of securities at price $ 8.75 per share. | 21 May 2025 | 11,428 | 34,879 | - | 8.8 | 99,995 | Common Stock |
| Olin Corp. | Edward M. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 9,157 | 9,157 | - | - | Phantom Stock Units | |
| Olin Corp. | Edward M. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 492 | 9,649 | - | - | Phantom Stock Units | |
| Nasdaq Inc - Ordinary Shar... | Michelle Daly | SVP, Controller & PAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.30 per share. | 03 Apr 2025 | 424 | 17,247 (0%) | 0% | 78.3 | 33,199 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Michelle Daly | SVP, Controller & PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 2,169 | 18,051 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.72 per share. | 01 Apr 2025 | 604 | 103,489 (0%) | 0% | 244.7 | 147,811 | Common Stock |
| Nasdaq Inc - Ordinary Shar... | Michelle Daly | SVP, Controller & PAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.86 per share. | 01 Apr 2025 | 380 | 17,671 (0%) | 0% | 75.9 | 28,827 | Common Stock, par value $0.01 per share |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 05 Mar 2025 | 46,936 | 32,606 (0%) | 0% | 8.7 | 409,751 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.88 per share. | 05 Mar 2025 | 43,064 | 79,542 (0%) | 0% | 8.9 | 382,408 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 194,064 | 194,064 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 97,032 | 97,032 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 90,580 | 133,644 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 90,580 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 38,226 | 53,928 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 38,226 | 76,453 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 35,879 | 107,640 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 35,879 | 138,185 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.76 per share. | 03 Mar 2025 | 31,338 | 102,306 (0%) | 0% | 8.8 | 274,521 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 22,645 | 22,645 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 22,645 | 22,645 (0%) | 0% | - | Class A Common Stock | |
| Kimbell Royalty Partners L... | Matthew S. Daly | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.42 per share. | 03 Mar 2025 | 16,725 | 682,843 (2%) | 0% | 14.4 | 241,175 | Common units representing limited partner interests |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.84 per share. | 03 Mar 2025 | 15,579 | 122,606 (0%) | 0% | 8.8 | 137,718 | Class A Common Stock |
| Kimbell Royalty Partners L... | Matthew S. Daly | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.32 per share. | 03 Mar 2025 | 14,717 | 712,587 (2%) | 0% | 15.3 | 225,464 | Common units representing limited partner interests |
| Kimbell Royalty Partners L... | Matthew S. Daly | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.32 per share. | 03 Mar 2025 | 13,019 | 699,568 (2%) | 0% | 15.3 | 199,451 | Common units representing limited partner interests |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.76 per share. | 03 Mar 2025 | 10,864 | 43,064 (0%) | 0% | 8.8 | 95,169 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.76 per share. | 03 Mar 2025 | 6,943 | 15,702 (0%) | 0% | 8.8 | 60,821 | Class A Common Stock |
| Madrigal Pharmaceuticals Inc | James M. Daly | Director | Sale of securities on an exchange or to another person at price $ 347.39 per share. | 27 Feb 2025 | 14,302 | 2,682 (0%) | 0% | 347.4 | 4,968,372 | Common Stock |
| Madrigal Pharmaceuticals Inc | James M. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 9,470 | 0 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | James M. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.06 per share. | 27 Feb 2025 | 9,470 | 11,382 (0%) | 0% | 65.1 | 616,118 | Common Stock |
| Madrigal Pharmaceuticals Inc | James M. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.06 per share. | 27 Feb 2025 | 6,000 | 17,382 (0%) | 0% | 111.1 | 666,360 | Common Stock |
| Madrigal Pharmaceuticals Inc | James M. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 6,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | James M. Daly | Director | Sale of securities on an exchange or to another person at price $ 348.94 per share. | 27 Feb 2025 | 770 | 1,912 (0%) | 0% | 348.9 | 268,686 | Common Stock |
| Madrigal Pharmaceuticals Inc | James M. Daly | Director | Sale of securities on an exchange or to another person at price $ 346.90 per share. | 27 Feb 2025 | 398 | 16,984 (0%) | 0% | 346.9 | 138,067 | Common Stock |
| Kimbell Royalty Partners L... | Matthew S. Daly | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 153,000 | 727,304 (2%) | 0% | 0 | Common units representing limited partner interests | |
| Nasdaq Inc - Ordinary Shar... | Michelle Daly | Controller and Prin Acctg Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 5,514 | 17,937 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Nasdaq Inc - Ordinary Shar... | Michelle Daly | Controller and Prin Acctg Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.24 per share. | 19 Feb 2025 | 2,056 | 15,882 (0%) | 0% | 81.2 | 167,029 | Common Stock, par value $0.01 per share |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 4,000 | 271,338 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 4,000 | 2,234,753 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 14 Feb 2025 | 1,574 | 269,764 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Blackboxstocks Inc | Dalya Sulaiman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 5,000 | 8,750 | - | - | Common Stock Options | |
| CareCloud Inc | John N. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 7,500 | 30,000 | - | - | Restricted Stock Unit | |
| CareCloud Inc | John N. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 7,500 | 76,750 (0%) | 0% | 0 | Common Stock | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 4,241 | 4,241 | - | - | Stock Option (Right to Buy) | |
| CareCloud Inc | John N. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 7,500 | 37,500 | - | - | Restricted Stock Unit | |
| CareCloud Inc | John N. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 7,500 | 69,250 (0%) | 0% | 0 | Common Stock | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 42,105 | 277,938 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 42,105 | 2,238,753 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2025 | 10,600 | 267,338 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| CareCloud Inc | John N. Daly | Director | Sale of securities on an exchange or to another person at price $ 3.87 per share. | 31 Dec 2024 | 5,000 | 61,750 (0%) | 0% | 3.9 | 19,350 | Common Stock |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 1,333 | 2,280,858 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 1,333 | 236,157 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Dec 2024 | 324 | 235,833 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| CareCloud Inc | John N. Daly | Director | Sale of securities on an exchange or to another person at price $ 3.65 per share. | 02 Dec 2024 | 10,000 | 66,750 (0%) | 0% | 3.7 | 36,500 | Common Stock |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 491,160 | 2,222,172 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 60,019 | 2,282,191 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | SVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.40 per share. | 21 Nov 2024 | 13,665 | 0 (0%) | 0% | 8.4 | 114,786 | Class A Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2024 | 1,000 | 104,093 (0%) | 0% | 0 | Common Stock | |
| Amneal Pharmaceuticals Inc... | Jason B. Daly | SVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.61 per share. | 15 Nov 2024 | 43,657 | 13,665 (0%) | 0% | 8.6 | 375,887 | Class A Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 129.62 per share. | 13 Nov 2024 | 25,727 | 56,721 (0%) | 0% | 129.6 | 3,334,734 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 128.65 per share. | 13 Nov 2024 | 13,644 | 82,448 (0%) | 0% | 128.7 | 1,755,301 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 130.43 per share. | 13 Nov 2024 | 5,729 | 50,992 (0%) | 0% | 130.4 | 747,233 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 110,619 | 166,445 (0%) | 0% | 0 | Common Stock | |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 139.14 per share. | 07 Nov 2024 | 49,061 | 117,384 (0%) | 0% | 139.1 | 6,826,348 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 134.27 per share. | 07 Nov 2024 | 9,679 | 101,567 (0%) | 0% | 134.3 | 1,299,599 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 135.25 per share. | 07 Nov 2024 | 4,775 | 96,792 (0%) | 0% | 135.3 | 645,819 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 133.45 per share. | 07 Nov 2024 | 4,241 | 111,246 (0%) | 0% | 133.4 | 565,961 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 137.86 per share. | 07 Nov 2024 | 1,897 | 115,487 (0%) | 0% | 137.9 | 261,520 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 136.73 per share. | 07 Nov 2024 | 700 | 96,092 (0%) | 0% | 136.7 | 95,711 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 111.81 per share. | 29 Oct 2024 | 3,456 | 59,492 (0%) | 0% | 111.8 | 386,415 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 112.77 per share. | 29 Oct 2024 | 2,817 | 56,675 (0%) | 0% | 112.8 | 317,673 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 119.33 per share. | 29 Oct 2024 | 1,583 | 63,794 (0%) | 0% | 119.3 | 188,899 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 120.04 per share. | 29 Oct 2024 | 846 | 62,948 (0%) | 0% | 120.0 | 101,554 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 114.25 per share. | 29 Oct 2024 | 649 | 56,026 (0%) | 0% | 114.2 | 74,148 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 117.55 per share. | 29 Oct 2024 | 200 | 65,377 (0%) | 0% | 117.6 | 23,510 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 115.88 per share. | 29 Oct 2024 | 200 | 55,826 (0%) | 0% | 115.9 | 23,176 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 117.79 per share. | 27 Oct 2024 | 3,742 | 66,577 (0%) | 0% | 117.8 | 440,770 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.70 per share. | 27 Oct 2024 | 3,581 | 72,416 (0%) | 0% | 121.7 | 435,808 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.54 per share. | 27 Oct 2024 | 2,097 | 70,319 (0%) | 0% | 117.5 | 246,481 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 119.71 per share. | 27 Oct 2024 | 300 | 66,077 (0%) | 0% | 119.7 | 35,913 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 120.88 per share. | 27 Oct 2024 | 300 | 65,777 (0%) | 0% | 120.9 | 36,264 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 118.87 per share. | 27 Oct 2024 | 200 | 66,377 (0%) | 0% | 118.9 | 23,774 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 121.80 per share. | 27 Oct 2024 | 200 | 65,577 (0%) | 0% | 121.8 | 24,360 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 11,525 | 75,997 (0%) | 0% | 0 | Common Stock | |
| Instructure Holdings Inc | Steve Daly | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2024 | 202,000 | 1,784,358 | - | - | Common Stock, $0.01 par value per share | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 14,510 | 0 | - | - | Stock Option (Right to Buy) | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.34 per share. | 06 Sep 2024 | 14,510 | 127,031 (0%) | 0% | 117.3 | 1,702,603 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 207.66 per share. | 06 Sep 2024 | 12,900 | 105,093 (0%) | 0% | 207.7 | 2,678,849 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 207.66 per share. | 06 Sep 2024 | 9,038 | 117,993 (0%) | 0% | 207.7 | 1,876,855 | Common Stock |
| Instructure Holdings Inc | Steve Daly | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.39 per share. | 01 Sep 2024 | 22,973 | 1,986,358 | - | 23.4 | 537,338 | Common Stock, $0.01 par value per share |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 109.05 per share. | 30 Aug 2024 | 11,985 | 73,499 (0%) | 0% | 109.0 | 1,306,964 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 109.75 per share. | 30 Aug 2024 | 7,925 | 65,574 (0%) | 0% | 109.8 | 869,769 | Common Stock |
| MACOM Technology Solutions... | Stephen G. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 110.64 per share. | 30 Aug 2024 | 1,102 | 64,472 (0%) | 0% | 110.6 | 121,925 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 1,239 | 112,521 (0%) | 0% | 0 | Common Stock | |
| CareCloud Inc | John N. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 30,000 | 45,000 | - | - | Restricted Stock Unit | |
| CareCloud Inc | John N. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 7,500 | 71,750 (0%) | 0% | 0 | Common Stock | |
| CareCloud Inc | John N. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 7,500 | 20,000 | - | - | Restricted Stock Unit | |
| CareCloud Inc | John N. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 5,000 | 15,000 | - | - | Restricted Stock Unit | |
| CareCloud Inc | John N. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 5,000 | 76,750 (0%) | 0% | 0 | Common Stock | |
| Nasdaq Inc - Ordinary Shar... | Michelle Daly | Controller and Prin Acctg Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.48 per share. | 01 Jul 2024 | 1,126 | 12,423 (0%) | 0% | 59.5 | 66,974 | Common Stock, par value $0.01 per share |
| Madrigal Pharmaceuticals Inc | James M. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 1,105 | 1,105 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | James M. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 714 | 1,912 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges